Skip to Main Content

NEWS & RESOURCES

Bioscience

Tariffs, TrumpRx, and the Shift to DTC Prescription Drug Sales

The following article was first posted in the Insights section of Mercer’s website. It is reposted here with permission. It’s been an eventful year for the pharmacy…

Jackson Lab Acquires NY Stem Cell Foundation

The Jackson Laboratory has completed its acquisition of the New…

State Makes $50M New Haven Innovation Investment

The Lamont administration announced a $50.5 million investment in downtown…

Content Type:

Bioscience

Tariffs, TrumpRx, and the Shift to DTC Prescription Drug Sales

The following article was first posted in the Insights section of...

Bioscience

Jackson Lab Acquires NY Stem Cell Foundation

The Jackson Laboratory has completed its acquisition of the...

Bioscience

State Makes $50M New Haven Innovation Investment

The Lamont administration announced a $50.5 million investment in...

Bioscience

Time to Undo the Pill Penalty

The following article first appeared in the Connecticut Mirror’s...

Bioscience

Arvinas board chair John Houston

John Houston Stepping Down as Arvinas CEO

New Haven-based biotech company Arvinas has begun the search...

Bioscience

CBIA BizCast: Reflecting on a Bioscience Career

He’s not calling it retirement. But after a successful...

Bioscience

Legislative Session: Near Misses, Notable Successes for Bioscience

From the perspective of the biopharma sector, the 2025...

Bioscience

ViiV Healthcare team

ViiV Healthcare’s HIV, AIDS Efforts Recognized

Branford pharmaceutical company ViiV Healthcare is being recognized for...

Bioscience

Amended Healthcare Regulatory Bill Heads to House

The state Senate passed omnibus legislation imposing a broad...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.